SS 05 - Palliative 1: Faster, Less Toxic, and More Effective: A Holy Trinity in Palliative Radiotherapy

Moderator(s)

• 

  Mai Anh Huynh, MD, PhD

  Brigham and Women's Hospital/Dana-Farber
  Jamaica Plain, MA
• SR

  Shayna Rich, MD, PhD

  Haven Hospice
  Gainesville, FL

Presentations:

• 2:45 PM – 2:55 PM ET

  Efficacy of Kangfuxin Liquid Retention Enema in Preventing and Treating Radiation-Induced Proctitis in Cervical Cancer Patients: A Randomized, Open-Label, Phase III Study
  

  Presenter: Xiaojing Yang, PhD – Shanghai Sixth People's Hospital
• 2:55 PM – 3:05 PM ET

  Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial
  

  Presenter: Aiden Kooyman, BS – University of British Columbia
• 3:05 PM – 3:15 PM ET

  Impact of Clinical Target Volume Utilization on Outcomes in Patients with Non-Spine Bone Oligometastases Treated with Stereotactic Ablative Radiation Therapy
  

  Presenter: Emily O'Reilly, MD, BS – BC Cancer - Vancouver Centre
• 3:15 PM – 3:25 PM ET

  Real-world implementation of simulation-free radiotherapy (SFRT-1000): A propensity score-matched analysis of 1000 consecutive palliative courses delivered in routine care
  

  Presenter: Thilo Schuler, MD, MHInf – Northern Sydney Cancer Centre - Royal North Shore Hospital
• 3:25 PM – 3:35 PM ET

  Applying Deep Learning Based Facial Age Phenotyping to Improve Life Expectancy Prediction in Metastatic Cancer Patients Receiving Palliative Radiotherapy
  

  Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
• 3:35 PM – 3:45 PM ET

  Relationship between Cannabis Use and Opioid Use in Patients with Cancer Metastatic to Bone in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical Cannabis
  

  Presenter: Matthew Cousins, MD, PhD – Self Regional Healthcare
• 3:45 PM – 3:55 PM ET

  Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)
  

  Presenter: Slavisa Tubin, MD – MedAustron, Center for Ion Therapy and Research